IS Clinical Launches New ADVANCE+ Ski... ( Offers phenomenal breakthrough in Vi...)

IS Clinical Launches New ADVANCE+ Skincare Line

Date:6/19/2008

Offers phenomenal breakthrough in Vitamin C formulation technology seen in

over a decade

Available Globally in July 2008

NEW YORK, June 19 /PRNewswire/ -- IS Clinical, an exclusive skincare brand by INNOVATIVE SKINCARE, has raised the bar once again in formulation and ingredient technology with the highly-effective, clinically-validated skincare line: ADVANCE+.

The Innovative Skincare R&D team sourced a new version of L-Ascorbic Acid (Vitamin C) technology to employ in the ADVANCE+ formulas. This version of L-Ascorbic Acid offers time-released, continuous and steady delivery to cells, providing a more efficient and effective form of the powerhouse ingredient. Additionally, its uniquely stabilized molecular structure allows it to be formulated with other potent ingredients, previously thought impossible, to enable enhanced collagen production and additional anti-aging benefits.

Innovative Skincare's expert team of PhDs, under the direction of Medical Director Charlene DeHaven, MD, FACEP, directed the development of the line from concept to market, including: sourcing the ingredients worldwide and coordinated independent clinical testing on all formulations for safety and efficacy. In an effort to uphold supreme ethical standards and adhere to strict medical guidelines, Innovative Skincare is moving forward without the involvement of former R&D team member Dr. Mostafa Omar, and by extension Phytoceuticals, Inc.

The new ADVANCE+ line includes: Super Serum ADVANCE+, Pro-Heal Serum ADVANCE+, and C Eye ADVANCE+ and will launch globally in July 2008.

IS Clinical products are exclusively sold through dermatologists, plastic surgeons, medi-spas, and luxury professional skincare locations. To find a retailer near you, log on to http://www.innovativeskincare.com.

IS Clinical is the exclusive skincare brand by INNOV
'/>"/>

2

GOOD

Page: 1 2
Related biology technology :

1. PAREXEL Expands Global Clinical Logistics Capabilities
2. Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management
3. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
4. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
5. Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association
6. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
7. Cardium Launches New AWARE Clinical Study Website
8. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
9. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
10. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
11. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Post Your Comments:

IS Clinical Launches New ADVANCE+ Ski...( Offers phenomenal breakthrough in Vi...)